Literature DB >> 23916526

Progression of low-grade dysplasia to advanced neoplasia based on the location and morphology of dysplasia in ulcerative colitis patients with extensive colitis under colonoscopic surveillance.

Udayakumar Navaneethan1, Ramprasad Jegadeesan, Norma G Gutierrez, Preethi G K Venkatesh, Jeffrey P Hammel, Bo Shen, Ravi P Kiran.   

Abstract

BACKGROUND: The management of low-grade dysplasia (LGD) in ulcerative colitis (UC) patients remains unclear. AIM: The aim of our study was to study the risk of progression of LGD to advanced neoplasia (AN), defined as high-grade dysplasia (HGD) or colorectal cancer (CRC) for UC patients undergoing surveillance based on location and morphology of LGD.
METHODS: 997 UC patients underwent 3152 surveillance colonoscopies from 1998 to 2011. Kaplan-Meier estimates and incidence rates calculated.
RESULTS: Of the 102 patients with LGD (65 raised and 37 flat), 5 (4.9%) patients progressed to AN (3 HGD and 2 CRC) after a median follow-up of 36 months (interquartile range 18-71 months). Initial location of dysplasia was in the proximal colon in 47, distal colon in 55 patients. Four of the 5 (80%) patients with AN had initial dysplasia in the distal colon. Distal colonic LGD had an incidence rate for AN of 2.1 cases per 100 person years at risk, while proximal LGD had an incidence of 0.5 cases per 100 person years. Flat LGD in the distal colon was more likely to progress to AN [hazard ratio=3.6; 95% confidence interval, CI (1.3-10.6)]. Twenty of the 102 patients (15 flat and 5 raised) underwent colectomy: 2 (10%) had evidence of AN in colectomy (1 HGD and 1 CRC), 9 had LGD and remaining 9 did not have dysplasia.
CONCLUSIONS: The frequency of progression of LGD to AN is low. Flat dysplasia located in the distal colon is associated with a greater risk of progression to AN.
Copyright © 2013 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5-ASA; 5-aminosalicylic acid; ACG; AN; American College of Gastroenterology; CD; CI; Crohn's disease; DALM; Flat dysplasia; HGD; HR; IBD; IC; LGD; Low-grade dysplasia; PSC; UC; UDCA; Ulcerative colitis; advanced neoplasia; confidence interval; dysplasia associated lesion or mass; hazard ratio; high-grade dysplasia; indeterminate colitis; inflammatory bowel disease; low-grade dysplasia; primary sclerosing cholangitis; ulcerative colitis; ursodeoxycholic acid

Mesh:

Year:  2013        PMID: 23916526     DOI: 10.1016/j.crohns.2013.06.006

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN: 1873-9946            Impact factor:   9.071


  18 in total

Review 1.  Chromoendoscopy for colorectal cancer surveillance in patients with inflammatory bowel disease.

Authors:  Samir A Shah; David T Rubin; Francis A Farraye
Journal:  Curr Gastroenterol Rep       Date:  2014-09

Review 2.  An Update on Surveillance in Ulcerative Colitis.

Authors:  Jimmy K Limdi; Francis A Farraye
Journal:  Curr Gastroenterol Rep       Date:  2018-03-07

Review 3.  Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.

Authors:  A Boudewijn de Vries; Marcel Janse; Hans Blokzijl; Rinse K Weersma
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

4.  Advances in the Diagnosis and Management of Colonic Dysplasia in Patients With Inflammatory Bowel Disease.

Authors:  Shirley Cohen-Mekelburg; Yecheskel Schneider; Stephanie Gold; Ellen Scherl; Adam Steinlauf
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-06

Review 5.  Incidence, Risk Factors, and Outcomes of Colorectal Cancer in Patients With Ulcerative Colitis With Low-Grade Dysplasia: A Systematic Review and Meta-analysis.

Authors:  Mathurin Fumery; Parambir S Dulai; Samir Gupta; Larry J Prokop; Sonia Ramamoorthy; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2016-12-01       Impact factor: 11.382

Review 6.  Colorectal cancer risk of flat low-grade dysplasia in inflammatory bowel disease: a systematic review and proportion meta-analysis.

Authors:  Sara Lauricella; Silvia Fabris; Patricia Sylla
Journal:  Surg Endosc       Date:  2022-08-03       Impact factor: 3.453

Review 7.  Colorectal Cancer in Inflammatory Bowel Disease.

Authors:  Ryan W Stidham; Peter D R Higgins
Journal:  Clin Colon Rectal Surg       Date:  2018-04-01

Review 8.  Colorectal Cancer Screening in Inflammatory Bowel Disease.

Authors:  Neil Sengupta; Eric Yee; Joseph D Feuerstein
Journal:  Dig Dis Sci       Date:  2015-12-08       Impact factor: 3.199

9.  Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.

Authors:  Sanjiban Chakrabarty; Vinay Koshy Varghese; Pranoy Sahu; Pradyumna Jayaram; Bhadravathi M Shivakumar; Cannanore Ganesh Pai; Kapaettu Satyamoorthy
Journal:  Br J Cancer       Date:  2017-05-18       Impact factor: 7.640

Review 10.  Microparticles as controlled drug delivery carrier for the treatment of ulcerative colitis: A brief review.

Authors:  Muzamil Rashid; Veerpal Kaur; Supandeep Singh Hallan; Saurabh Sharma; Neeraj Mishra
Journal:  Saudi Pharm J       Date:  2014-10-22       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.